Ukrain modulates glial fibrillary acidic protein, but not connexin 43 expression, and induces apoptosis in human cultured glioblastoma cells

Nicoletta Gagliano, Claudia Moscheni, Carlo Torri, Elena Donetti, Ivana Magnani, Francesco Costa, Wassil Nowicky, Magda Gioia

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Glioblastoma is a highly malignant tumor, characterized by an unfavorable prognosis even in response to multidisciplinary treatment strategies, owing to its high-invasive phenotype. Ukrain, a semisynthetic thiophosphoric acid derivative of the purified alkaloid chelidonine, has been used in the therapy of several solid tumors, but little is known about its effect on glioblastoma and, in general, about the molecular mechanisms responsible for its effects. In particular, we previously demonstrated that Ukrain modulates the expression of genes and proteins involved in tumor invasion, and here we investigate some unreported effects of Ukrain on human cultured glioblastoma cells. We used morphological and molecular biology methods to analyze the expression and the intracellular distribution pattern of glial fibrillary acidic protein, the expression of the gap junction protein connexin 43 and the apoptotic effect in human glioblastoma cells treated with 0.1, 1 and 10 μmol/l Ukrain for 72 h. After treatment with 10 μmol/l Ukrain, glial fibrillary acidic protein fluorescence increased and a higher number of cells displayed glial fibrillary acidic protein organized into a filamentous state. Western blot analysis of glial fibrillary acidic protein confirmed that Ukrain tended to upregulate the protein. Connexin 43 was not modulated by Ukrain both at the mRNA and at the protein level. Ukrain-induced apoptotic rate was 4.63, 10.9 and 28.9% after 0.1, 1 and 10 μmol/l Ukrain, respectively, likely mediated by cytochrome c release in the cytoplasm. Considered as a whole, these findings provide new information to complete the understanding of the mechanisms of Ukrain antitumor and chemopreventive effect, and support the possible potential of Ukrain for the therapy of brain tumors.

Original languageEnglish
Pages (from-to)669-676
Number of pages8
JournalAnti-Cancer Drugs
Volume18
Issue number6
DOIs
Publication statusPublished - Jul 2007

Fingerprint

ukrain
Connexin 43
Glial Fibrillary Acidic Protein
Glioblastoma
Cultured Cells
Apoptosis
Neoplasms
Proteins
Connexins

Keywords

  • Apoptosis
  • Connexin 43
  • Cytochrome c
  • Glial fibrillary acidic protein
  • Glioblastoma
  • Ukrain

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Pharmacology

Cite this

Ukrain modulates glial fibrillary acidic protein, but not connexin 43 expression, and induces apoptosis in human cultured glioblastoma cells. / Gagliano, Nicoletta; Moscheni, Claudia; Torri, Carlo; Donetti, Elena; Magnani, Ivana; Costa, Francesco; Nowicky, Wassil; Gioia, Magda.

In: Anti-Cancer Drugs, Vol. 18, No. 6, 07.2007, p. 669-676.

Research output: Contribution to journalArticle

Gagliano, Nicoletta ; Moscheni, Claudia ; Torri, Carlo ; Donetti, Elena ; Magnani, Ivana ; Costa, Francesco ; Nowicky, Wassil ; Gioia, Magda. / Ukrain modulates glial fibrillary acidic protein, but not connexin 43 expression, and induces apoptosis in human cultured glioblastoma cells. In: Anti-Cancer Drugs. 2007 ; Vol. 18, No. 6. pp. 669-676.
@article{03f3c4aac0ad4a1c9037d05ee159c41f,
title = "Ukrain modulates glial fibrillary acidic protein, but not connexin 43 expression, and induces apoptosis in human cultured glioblastoma cells",
abstract = "Glioblastoma is a highly malignant tumor, characterized by an unfavorable prognosis even in response to multidisciplinary treatment strategies, owing to its high-invasive phenotype. Ukrain, a semisynthetic thiophosphoric acid derivative of the purified alkaloid chelidonine, has been used in the therapy of several solid tumors, but little is known about its effect on glioblastoma and, in general, about the molecular mechanisms responsible for its effects. In particular, we previously demonstrated that Ukrain modulates the expression of genes and proteins involved in tumor invasion, and here we investigate some unreported effects of Ukrain on human cultured glioblastoma cells. We used morphological and molecular biology methods to analyze the expression and the intracellular distribution pattern of glial fibrillary acidic protein, the expression of the gap junction protein connexin 43 and the apoptotic effect in human glioblastoma cells treated with 0.1, 1 and 10 μmol/l Ukrain for 72 h. After treatment with 10 μmol/l Ukrain, glial fibrillary acidic protein fluorescence increased and a higher number of cells displayed glial fibrillary acidic protein organized into a filamentous state. Western blot analysis of glial fibrillary acidic protein confirmed that Ukrain tended to upregulate the protein. Connexin 43 was not modulated by Ukrain both at the mRNA and at the protein level. Ukrain-induced apoptotic rate was 4.63, 10.9 and 28.9{\%} after 0.1, 1 and 10 μmol/l Ukrain, respectively, likely mediated by cytochrome c release in the cytoplasm. Considered as a whole, these findings provide new information to complete the understanding of the mechanisms of Ukrain antitumor and chemopreventive effect, and support the possible potential of Ukrain for the therapy of brain tumors.",
keywords = "Apoptosis, Connexin 43, Cytochrome c, Glial fibrillary acidic protein, Glioblastoma, Ukrain",
author = "Nicoletta Gagliano and Claudia Moscheni and Carlo Torri and Elena Donetti and Ivana Magnani and Francesco Costa and Wassil Nowicky and Magda Gioia",
year = "2007",
month = "7",
doi = "10.1097/CAD.0b013e32808bf9ec",
language = "English",
volume = "18",
pages = "669--676",
journal = "Anti-Cancer Drugs",
issn = "0959-4973",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Ukrain modulates glial fibrillary acidic protein, but not connexin 43 expression, and induces apoptosis in human cultured glioblastoma cells

AU - Gagliano, Nicoletta

AU - Moscheni, Claudia

AU - Torri, Carlo

AU - Donetti, Elena

AU - Magnani, Ivana

AU - Costa, Francesco

AU - Nowicky, Wassil

AU - Gioia, Magda

PY - 2007/7

Y1 - 2007/7

N2 - Glioblastoma is a highly malignant tumor, characterized by an unfavorable prognosis even in response to multidisciplinary treatment strategies, owing to its high-invasive phenotype. Ukrain, a semisynthetic thiophosphoric acid derivative of the purified alkaloid chelidonine, has been used in the therapy of several solid tumors, but little is known about its effect on glioblastoma and, in general, about the molecular mechanisms responsible for its effects. In particular, we previously demonstrated that Ukrain modulates the expression of genes and proteins involved in tumor invasion, and here we investigate some unreported effects of Ukrain on human cultured glioblastoma cells. We used morphological and molecular biology methods to analyze the expression and the intracellular distribution pattern of glial fibrillary acidic protein, the expression of the gap junction protein connexin 43 and the apoptotic effect in human glioblastoma cells treated with 0.1, 1 and 10 μmol/l Ukrain for 72 h. After treatment with 10 μmol/l Ukrain, glial fibrillary acidic protein fluorescence increased and a higher number of cells displayed glial fibrillary acidic protein organized into a filamentous state. Western blot analysis of glial fibrillary acidic protein confirmed that Ukrain tended to upregulate the protein. Connexin 43 was not modulated by Ukrain both at the mRNA and at the protein level. Ukrain-induced apoptotic rate was 4.63, 10.9 and 28.9% after 0.1, 1 and 10 μmol/l Ukrain, respectively, likely mediated by cytochrome c release in the cytoplasm. Considered as a whole, these findings provide new information to complete the understanding of the mechanisms of Ukrain antitumor and chemopreventive effect, and support the possible potential of Ukrain for the therapy of brain tumors.

AB - Glioblastoma is a highly malignant tumor, characterized by an unfavorable prognosis even in response to multidisciplinary treatment strategies, owing to its high-invasive phenotype. Ukrain, a semisynthetic thiophosphoric acid derivative of the purified alkaloid chelidonine, has been used in the therapy of several solid tumors, but little is known about its effect on glioblastoma and, in general, about the molecular mechanisms responsible for its effects. In particular, we previously demonstrated that Ukrain modulates the expression of genes and proteins involved in tumor invasion, and here we investigate some unreported effects of Ukrain on human cultured glioblastoma cells. We used morphological and molecular biology methods to analyze the expression and the intracellular distribution pattern of glial fibrillary acidic protein, the expression of the gap junction protein connexin 43 and the apoptotic effect in human glioblastoma cells treated with 0.1, 1 and 10 μmol/l Ukrain for 72 h. After treatment with 10 μmol/l Ukrain, glial fibrillary acidic protein fluorescence increased and a higher number of cells displayed glial fibrillary acidic protein organized into a filamentous state. Western blot analysis of glial fibrillary acidic protein confirmed that Ukrain tended to upregulate the protein. Connexin 43 was not modulated by Ukrain both at the mRNA and at the protein level. Ukrain-induced apoptotic rate was 4.63, 10.9 and 28.9% after 0.1, 1 and 10 μmol/l Ukrain, respectively, likely mediated by cytochrome c release in the cytoplasm. Considered as a whole, these findings provide new information to complete the understanding of the mechanisms of Ukrain antitumor and chemopreventive effect, and support the possible potential of Ukrain for the therapy of brain tumors.

KW - Apoptosis

KW - Connexin 43

KW - Cytochrome c

KW - Glial fibrillary acidic protein

KW - Glioblastoma

KW - Ukrain

UR - http://www.scopus.com/inward/record.url?scp=34548357033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548357033&partnerID=8YFLogxK

U2 - 10.1097/CAD.0b013e32808bf9ec

DO - 10.1097/CAD.0b013e32808bf9ec

M3 - Article

C2 - 17762395

AN - SCOPUS:34548357033

VL - 18

SP - 669

EP - 676

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

SN - 0959-4973

IS - 6

ER -